1 min read

Learn how Zensar's acquisition of BridgeView Life Sciences strengthens its life sciences and pharmaceutical capabilities. By combining Zensar's global scale, digital engineering, Salesforce and Veeva expertise with BridgeView's deep commercialization and product launch knowledge, organizations can accelerate pharmaceutical launches, improve commercial operations, and drive better patient and business outcomes.

Let's connect

Let's connect

Stay ahead with the latest updates or kick off an exciting conversation with us today!

Subscription Options